KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacira BioSciences (PCRX) Depreciation and Depletion: 2011-2025

Historic Depreciation and Depletion for Pacira BioSciences (PCRX) over the last 15 years, with Sep 2025 value amounting to $6.9 million.

  • Pacira BioSciences' Depreciation and Depletion rose 15.00% to $6.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.6 million, marking a year-over-year increase of 78.72%. This contributed to the annual value of $21.5 million for FY2024, which is 17.49% up from last year.
  • Per Pacira BioSciences' latest filing, its Depreciation and Depletion stood at $6.9 million for Q3 2025, which was down 46.92% from $13.0 million recorded in Q2 2025.
  • Pacira BioSciences' Depreciation and Depletion's 5-year high stood at $16.2 million during Q4 2022, with a 5-year trough of $2.9 million in Q1 2021.
  • Over the past 3 years, Pacira BioSciences' median Depreciation and Depletion value was $5.3 million (recorded in 2023), while the average stood at $6.0 million.
  • In the last 5 years, Pacira BioSciences' Depreciation and Depletion surged by 200.00% in 2022 and then plummeted by 74.07% in 2023.
  • Quarterly analysis of 5 years shows Pacira BioSciences' Depreciation and Depletion stood at $5.4 million in 2021, then surged by 200.00% to $16.2 million in 2022, then plummeted by 74.07% to $4.2 million in 2023, then spiked by 64.29% to $6.9 million in 2024, then climbed by 15.00% to $6.9 million in 2025.
  • Its Depreciation and Depletion was $6.9 million in Q3 2025, compared to $13.0 million in Q2 2025 and $6.8 million in Q1 2025.